EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Combination of Lactoferrin and Creatine Ameliorates Muscle Decay in a Sarcopenia Murine Model

Wenbin Wu iD, Xinlu Guo, Taiqi Qu, Yuejia Huang, Jin Tao, Jian He, Xiaoping Wang, Junjie Luo iD, Peng An, Yinhua Zhu, Yanan Sun, Yongting Luo iD

Nutrients · 19.06.2024 · 16 (12) · 1958

DOI: 10.3390/nu16121958 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 19.06.2024. Verfasst von Wenbin Wu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Precision Nutrition and Food Quality, Department of Nutrition and Health, China Agricultural University, Beijing 100193, China. Hauptthemen laut MEDLINE: Lactoferrin, Sarcopenia, Mice, Inbred C57BL, Creatine. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sarcopenia is an age-related condition characterized by progressive loss of muscle mass, strength, and function. The occurrence of sarcopenia has a huge impact on physical, psychological, and social health. Therefore, the prevention and treatment of sarcopenia is becoming an important public health issue.

Method

35 six-week-old male C57BL/6 mice were randomly divided into five groups, one of which served as a control group, while the rest of the groups were constructed as a model of sarcopenia by intraperitoneal injection of D-galactose. The intervention with lactoferrin, creatine, and their mixtures, respectively, was carried out through gavage for 8 weeks. Muscle function was assessed based on their endurance, hanging time, and grip strength. The muscle tissues were weighed to assess the changes in mass, and the muscle RNA was extracted for myogenic factor expression and transcriptome sequencing to speculate on the potential mechanism of action by GO and KEGG enrichment analysis.

Result

The muscle mass (lean mass, GAS index), and muscle function (endurance, hanging time, and grip strength) decreased, and the size and structure of myofiber was smaller in the model group compared to the control group. The intervention with lactoferrin and creatine, either alone or combination, improved muscle mass and function, restored muscle tissue, and increased the expression of myogenic regulators. The combined group demonstrated the most significant improvement in these indexes. The RNA-seq results revealed enrichment in the longevity-regulated pathway, MAPK pathway, focal adhesion, and ECM–receptor interaction pathway in the intervention group. The intervention group may influence muscle function by affecting the proliferation, differentiation, senescence of skeletal muscle cell, and contraction of muscle fiber. The combined group also enriched the mTOR-S6K/4E-BPs signaling pathway, PI3K-Akt signaling pathway, and energy metabolism-related pathways, including Apelin signaling, insulin resistance pathway, and adipocytokine signaling pathway, which affect energy metabolism in muscle.

Conclusions

Lactoferrin and creatine, either alone or in combination, were found to inhibit the progression of sarcopenia by influencing the number and cross-sectional area of muscle fibers and muscle protein synthesis. The combined intervention appears to exert a more significant effect on energy metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LactoferrinSarcopeniaMice, Inbred C57BLCreatineDisease Models, AnimalMuscle, SkeletalAnimalsMaleMiceMuscle StrengthSignal Transduction

Stichwörter der Autor:innen

creatineenergy metabolismlactoferrinmuscle masssarcopenia

Substanzen

LactoferrinCreatine

Autor:innen und Institutionen

  • Key Laboratory of Precision Nutrition and Food Quality, Department of Nutrition and Health, China Agricultural University, Beijing 100193, China.
  • National Center of Technology Innovation for Dairy, Hohhot 010110, China.
  • Zhejiang Medicine Co., Ltd., Shaoxing 312366, China.
  • Food Laboratory of Zhongyuan, Luohe 462300, China.

ORCID-Profile: Wenbin Wu, Junjie Luo, Yongting Luo

Förderung

  • National Key R&D Program of China
  • National Key Research and Development Program of China

Zitieren

APA

Wu, W., Guo, X., Qu, T., Huang, Y., Tao, J., He, J., Wang, X., Luo, J., An, P., Zhu, Y., Sun, Y., & Luo, Y. (2024). The Combination of Lactoferrin and Creatine Ameliorates Muscle Decay in a Sarcopenia Murine Model. Nutrients, 16(12), 1958. https://doi.org/10.3390/nu16121958

Vancouver

Wu W, Guo X, Qu T, Huang Y, Tao J, He J, et al. The Combination of Lactoferrin and Creatine Ameliorates Muscle Decay in a Sarcopenia Murine Model. Nutrients. 2024;16(12):1958. doi:10.3390/nu16121958

BibTeX
@article{Wu2024,
  author = {Wu, Wenbin and Guo, Xinlu and Qu, Taiqi and Huang, Yuejia and Tao, Jin and He, Jian and Wang, Xiaoping and Luo, Junjie and An, Peng and Zhu, Yinhua and Sun, Yanan and Luo, Yongting},
  title = {The Combination of Lactoferrin and Creatine Ameliorates Muscle Decay in a Sarcopenia Murine Model},
  journal = {Nutrients},
  year = {2024},
  volume = {16},
  number = {12},
  pages = {1958},
  doi = {10.3390/nu16121958}
}
Kostenlos starten →